NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

醫藥品有效成分 (API)的市場趨勢·市場佔有率·市場規模的預測 (2021-2028年):合成類型·製造區分·藥物區分·用途·各地區

Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2021 - 2028

出版商 Grand View Research, Inc. 商品編碼 989728
出版日期 內容資訊 英文 191 Pages
商品交期: 2-10個工作天內
價格
醫藥品有效成分 (API)的市場趨勢·市場佔有率·市場規模的預測 (2021-2028年):合成類型·製造區分·藥物區分·用途·各地區 Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2021 - 2028
出版日期: 2021年02月10日內容資訊: 英文 191 Pages
簡介

全球醫藥品有效成分 (API)的市場規模在預測期間內預計將以6.6%的年複合成長率推移,到2028年前將成長到3125億6000萬美元的規模。生物醫藥品部門的成長,API製造的進步,老年人口的增加等要素將推動該市場的成長。

本報告提供全球醫藥品有效成分 (API)的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的轉變·預測,主要的API的展望,合成類型·製造區分·藥物區分·用途·地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊。

第1章 調查手法·調查範圍

第2章 摘要整理

第3章 市場可變因素·趨勢·展望

  • 市場預測
  • 普及·成長預測製圖
  • 用戶的觀點分析
  • 市場動態
  • 市場分析工具

第4章 API市場:競爭分析

  • 主要企業·近幾年的發展·影響分析
  • 企業的分類
  • 業者情勢
  • 公開企業
  • 非公開企業
  • 主要交易·策略性聯盟

第5章 API的展望

  • 銷售量的轉變
  • 按企業的地位:API
    • Amoxicillin
    • Azithromycin
    • Bleomycin
    • Caspofungin
    • Clarithromycin
    • Clavulanic acid
    • Clindamycin
    • Compactin (Mevastatin)
    • Cyclosporin
    • Dactinomycin
    • Daptomycin
    • Demeclocycline
    • Doxycycline
    • Erythromycin
    • Ivermectin (Avermectin)
    • Lovastatin
    • Micafungin
    • Minocycline
    • Mitomycin
    • Mycophenolic acid
    • Pneumocandin B0
    • Polymyxin
    • Pravastatin
    • Rapamycin (Sirolimus)
    • Simvastatin
    • Steroids
    • Tacrolimus
    • Tetracycline
    • Tigecycline
    • Tobramycin
    • Vancomycin
  • 價格比較分析

第6章 市場預測·趨勢分析:各合成類型

  • 儀表板
  • 市場佔有率實際成果·預測
  • 市場規模的轉變·預測
  • 生物TecAPI
  • 單株抗體
  • 重組蛋白質
  • 疫苗
  • 合成API

第7章 市場預測·趨勢分析:製造各種類

  • 儀表板
  • 市場佔有率實際成果·預測
  • 市場規模的轉變·預測
  • 自家公司用
  • 商用

第8章 市場預測·趨勢分析:各類型

  • 儀表板
  • 市場佔有率實際成果·預測
  • 市場規模的轉變·預測
  • 學名藥
  • 首發藥

第9章 市場預測·趨勢分析:各用途

  • 儀表板
  • 市場佔有率實際成果·預測
  • 市場規模的轉變·預測
  • 循環系統疾病
  • 腫瘤
  • 中樞神經系統和神經內科
  • 整形外科
  • 內分泌學
  • 呼吸系統內科
  • 消化器官內科
  • 腎臟內科
  • 眼科
  • 其他

第10章 市場預測·趨勢分析:各地區·主要國家

  • 儀表板
  • 市場佔有率實際成果·預測
  • 市場規模的轉變·預測
  • SWOT分析
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第11章 企業簡介

  • AbbVie, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Cipla, Inc.
  • Merck & Co., Inc.
  • Albemarle Corporation
  • Aurobindo Pharma
  • Viatris Inc. (Mylan N.V.)
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
目錄
Product Code: GVR-1-68038-348-5

Active Pharmaceutical Ingredient Market Growth & Trends

The global active pharmaceutical ingredients market size is expected to reach USD 312.56 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical ingredient (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The generic API segment is gaining share in the market owing to its cost effectiveness, which helps in catering to the needs of the rising number of patients in developing regions with a low-income population. According to the Association for Accessible Medicines (AAM), in 2017, there was a considerable rise in manufacturing units in Asia, Australia, and EU5. There has also been an increase in the market share of generic drugs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, other factors favoring India include quality raw materials and products, large workforce, vast distribution network, and government subsidies under schemes like "Make in India".

For addressing unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In August 2019, OmniChem Private Limited was acquired by Ajinomoto Bio-Pharma Services (earlier they were in a joint venture since 2011 for the manufacturing of APIs). The acquisition was completed in June 2020.

Active Pharmaceutical Ingredient Market Report Highlights

  • According to the WHO, around 17.5 million people die each year due to cardiovascular diseases, accounting for 31% of all deaths across the globe
  • The growing geriatric population in Asian countries, such as Japan and China, along with high untapped opportunities, is expected to drive the market during the forecast period. It is estimated that over 20% of the Japanese population is aged 65 and above
  • According to the CDC, about 795,000 people in the U.S. suffer from stroke every year, out of which 87% cases are of ischemic stroke
  • Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer or country
  • Key players are increasingly focusing on vaccines, for instance, Sanofi announced an investment of USD 601.37 million for vaccine production and research in France. These investments are anticipated to drive the development of new vaccine APIs in the coming years to help facilitate readiness to deliver new products

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Regional scope
    • 1.1.2 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 Key KoL Responses
  • 1.9 Market share calculations
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations
  • 1.12 Objectives
    • 1.12.1 Objective 1
    • 1.12.2 Objective 2
    • 1.12.3 Objective 3
    • 1.12.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Segment Outlook
  • 2.2 Competitive Outlook
  • 2.3 Market Outlook

Chapter 3 API Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 User Perspective Analysis
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Growing geriatric population
      • 3.4.1.2 Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
      • 3.4.1.3 Increasing preference for targeted therapy approach in cancer treatment
      • 3.4.1.4 Increasing preference for outsourcing APIs
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 High capital investments and production cost
      • 3.4.2.2 Stringent Safety and handling regulations regarding APIs
  • 3.5 Market Analysis Tools
    • 3.5.1 Industry Analysis: Porter's
    • 3.5.2 PESTLE Analysis
    • 3.5.3 Regulatory Scenario

Chapter 4 API Market: Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 4.1.1 Ansoff matrix
    • 4.1.2 Heat map analysis
  • 4.2 Company Categorization
    • 4.2.1 Innovators
    • 4.2.2 Market Leaders
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
    • 4.3.3 Key company market share analysis, 2020
  • 4.4 Public Companies
    • 4.4.1 Company market position analysis
    • 4.4.2 Company market position analysis
    • 4.4.3 Competitive Dashboard Analysis
      • 4.4.3.1 Market Differentiators
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
  • 4.6 Major Deals and Strategic Alliances Analysis
    • 4.6.1 Joint Ventures
    • 4.6.2 Acquisitions
    • 4.6.3 Licensing and Partnerships
    • 4.6.4 Technological Collaborations

Chapter 5 API Molecules Outlook

  • 5.1 Global Sales of API Molecules, USD Million, 2017 - 2020
  • 5.2 Companies with the leading market position for API molecules
    • 5.2.1 Amoxicillin
    • 5.2.2 Azithromycin
    • 5.2.3 Bleomycin
    • 5.2.4 Caspofungin
    • 5.2.5 Clarithromycin
    • 5.2.6 Clavulanic acid
    • 5.2.7 Clindamycin
    • 5.2.8 Compactin (Mevastatin)
    • 5.2.9 Cyclosporin
    • 5.2.10 Dactinomycin
    • 5.2.11 Daptomycin
    • 5.2.12 Demeclocycline
    • 5.2.13 Doxycycline
    • 5.2.14 Erythromycin
    • 5.2.15 Ivermectin (Avermectin)
    • 5.2.16 Lovastatin
    • 5.2.17 Micafungin
    • 5.2.18 Minocycline
    • 5.2.19 Mitomycin
    • 5.2.20 Mycophenolic acid
    • 5.2.21 Pneumocandin B0
    • 5.2.22 Polymyxin
    • 5.2.23 Pravastatin
    • 5.2.24 Rapamycin (Sirolimus)
    • 5.2.25 Simvastatin
    • 5.2.26 Steroids
    • 5.2.27 Tacrolimus
    • 5.2.28 Tetracycline
    • 5.2.29 Tigecycline
    • 5.2.30 Tobramycin
    • 5.2.31 Vancomycin
  • 5.3 Comparative price analysis of the above-mentioned molecules

Chapter 6 API Market: Segment Analysis, by Type of Synthesis, 2017 - 2028 (USD Billion)

  • 6.1 Definition and Scope
  • 6.2 Type of Synthesis Market Share Analysis, 2020 & 2028
  • 6.3 Segment Dashboard
  • 6.4 Global API Market, by Type of Synthesis, 2017 to 2028
  • 6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
    • 6.5.1 Biotech API
      • 6.5.1.1 Biotech API market, 2017 - 2028 (USD Billion)
    • 6.5.2 Monoclonal Antibodies
      • 6.5.2.1 Monoclonal antibodies market, 2017 - 2028 (USD Billion)
    • 6.5.3 Recombinant Proteins
      • 6.5.3.1 Recombinant proteins market, 2017 - 2028 (USD Billion)
    • 6.5.4 Vaccines
      • 6.5.4.1 Vaccines market, 2017 - 2028 (USD Billion)
    • 6.5.5 Synthetic API
      • 6.5.5.1 Synthetic API market, 2017 - 2028 (USD Billion)

Chapter 7 API Market: Segment Analysis, by Type of Manufacturer, 2017 - 2028 (USD Billion)

  • 7.1 Definition and Scope
  • 7.2 Type of Manufacturer Market Share Analysis, 2020 & 2028
  • 7.3 Segment Dashboard
  • 7.4 Global API Market, by Type of Manufacturers, 2017 to 2028
  • 7.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
    • 7.5.1 Captive API
      • 7.5.1.1 Captive API market, 2017 - 2028 (USD Billion)
    • 7.5.2 Merchant API
      • 7.5.2.1 Captive API market, 2017 - 2028 (USD Billion)

Chapter 8 API Market: Segment Analysis, by Type, 2017 - 2028 (USD Billion)

  • 8.1 Definition and Scope
  • 8.2 Type Market Share Analysis, 2020 & 2028
  • 8.3 Segment Dashboard
  • 8.4 Global API Market, by Type, 2017 to 2028
  • 8.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
    • 8.5.1 Generic APIS
      • 8.5.1.1 Generic APIs market, 2017 - 2028 (USD Billion)
    • 8.5.2 Innovative APIs
      • 8.5.2.1 Innovative APIS market, 2017 - 2028 (USD Billion)

Chapter 9 API Market: Segment Analysis, by Application, 2017 - 2028 (USD Billion)

  • 9.1 Definition and Scope
  • 9.2 Application Market Share Analysis, 2020 & 2028
  • 9.3 Segment Dashboard
  • 9.4 Global API Market, by Application, 2017 to 2028
  • 9.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
    • 9.5.1 Cardiovascular Diseases
      • 9.5.1.1 Cardiovascular diseases market, 2017 - 2028 (USD Billion)
    • 9.5.2 Oncology
      • 9.5.2.1 Oncology market, 2017 - 2028 (USD Billion)
    • 9.5.3 CNS and Neurology
      • 9.5.3.1 CNS and neurology market, 2017 - 2028 (USD Billion)
    • 9.5.4 Orthopedics
      • 9.5.4.1 Orthopedics market, 2017 - 2028 (USD Billion)
    • 9.5.5 Endocrinology
      • 9.5.5.1 Endocrinology market, 2017 - 2028 (USD Billion)
    • 9.5.6 Pulmonology
      • 9.5.6.1 Pulmonology market, 2017 - 2028 (USD Billion)
    • 9.5.7 Gastroenterology
      • 9.5.7.1 Gastroenterology market, 2017 - 2028 (USD Billion)
    • 9.5.8 Nephrology
      • 9.5.8.1 Nephrology market, 2017 - 2028 (USD Billion)
    • 9.5.9 Ophthalmology
      • 9.5.9.1 Ophthalmology market, 2017 - 2028 (USD Billion)
    • 9.5.10 Others
      • 9.5.10.1 Others market, 2017 - 2028 (USD Billion)

Chapter 10 API Market: Regional Market Analysis, 2017 - 2028 (USD Billion)

  • 10.1 Definition & Scope
  • 10.2 Regional Market Share Analysis, 2020 & 2028
  • 10.3 Regional Market Dashboard
  • 10.4 Regional Market Snapshot
  • 10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    • 10.5.1 North America
    • 10.5.2 Europe
    • 10.5.3 Asia Pacific
    • 10.5.4 Latin America
    • 10.5.5 MEA
  • 10.6 Market Size, & Forecasts, Trend Analysis, 2020 to 2028
  • 10.7 North America
    • 10.7.1 North America Market estimates and forecast, 2017 - 2028 (USD Billion)
    • 10.7.2 U.S.
      • 10.7.2.1 U.S. API market, 2017 - 2028 (USD Billion)
    • 10.7.3 Canada
      • 10.7.3.1 Canada API market, 2017 - 2028 (USD Billion)
  • 10.8 Europe
    • 10.8.1 Europe API market, 2017 - 2028 (USD Billion)
    • 10.8.2 U.K.
      • 10.8.2.1 U.K. API market, 2017 - 2028 (USD Billion)
    • 10.8.3 Germany
      • 10.8.3.1 Germany API market, 2017 - 2028 (USD Billion)
    • 10.8.4 Spain
      • 10.8.4.1 Spain API market, 2017 - 2028 (USD Billion)
    • 10.8.5 France
      • 10.8.5.1 France API market, 2017 - 2028 (USD Billion)
    • 10.8.6 Italy
      • 10.8.6.1 Italy API market, 2017 - 2028 (USD Billion)
    • 10.8.7 Russia
      • 10.8.7.1 Russia API market, 2017 - 2028 (USD Billion)
  • 10.9 Asia Pacific
    • 10.9.1 Asia Pacific API market, 2017 - 2028 (USD Billion)
    • 10.9.2 Japan
      • 10.9.2.1 Japan API market, 2017 - 2028 (USD Billion)
    • 10.9.3 China
      • 10.9.3.1 China API market, 2017 - 2028 (USD Billion)
    • 10.9.4 India
      • 10.9.4.1 India API market, 2017 - 2028 (USD Billion)
    • 10.9.5 South Korea
      • 10.9.5.1 South Korea API market, 2017 - 2028 (USD Billion)
    • 10.9.6 Australia
      • 10.9.6.1 Australia API market, 2017 - 2028 (USD Billion)
  • 10.10 Latin America
    • 10.10.1 Latin America API Market, 2017 - 2028 (USD Billion)
    • 10.10.2 Brazil
      • 10.10.2.1 Brazil API market, 2017 - 2028 (USD Billion)
    • 10.10.3 Mexico
      • 10.10.3.1 Mexico API market, 2017 - 2028 (USD Billion)
    • 10.10.4 Argentina
      • 10.10.4.1 Argentina API market, 2017 - 2028 (USD Billion)
  • 10.11 MEA
    • 10.11.1 MEA API market, 2017 - 2028 (USD Billion)
    • 10.11.2 South Africa
      • 10.11.2.1 South Africa API market, 2017 - 2028 (USD Billion)
    • 10.11.3 Saudi Arabia
      • 10.11.3.1 Saudi Arabia API market, 2017 - 2028 (USD Billion)
    • 10.11.4 UAE
      • 10.11.4.1 UAE API market, 2017 - 2028 (USD Billion)

Chapter 11 Company Profiles

  • 11.1 AbbVie, Inc.
    • 11.1.1 Company overview
    • 11.1.2 Financial performance
    • 11.1.3 Product benchmarking
    • 11.1.4 Strategic initiatives
  • 11.2 Boehringer Ingelheim International GmbH
    • 11.2.1 Company overview
    • 11.2.2 Financial performance
    • 11.2.3 Product benchmarking
    • 11.2.4 Strategic initiatives
  • 11.3 Bristol-Myers Squibb Company
    • 11.3.1 Company overview
    • 11.3.2 Financial performance
    • 11.3.3 Product benchmarking
    • 11.3.4 Strategic initiatives
  • 11.4 Cipla, Inc.
    • 11.4.1 Company overview
    • 11.4.2 Financial performance
    • 11.4.3 Product benchmarking
    • 11.4.4 Strategic initiatives
  • 11.5 Merck & Co., Inc.
    • 11.5.1 Company overview
    • 11.5.2 Financial performance
    • 11.5.3 Product benchmarking
    • 11.5.4 Strategic initiatives
  • 11.6 Albemarle Corporation
    • 11.6.1 Company overview
    • 11.6.2 Financial performance
    • 11.6.3 Product benchmarking
  • 11.7 Aurobindo Pharma
    • 11.7.1 Company overview
    • 11.7.2 Financial performance
    • 11.7.3 Product benchmarking
    • 11.7.4 Strategic initiatives
  • 11.8 Viatris Inc. (Mylan N.V.)
    • 11.8.1 Company overview
    • 11.8.2 Financial performance
    • 11.8.3 Product benchmarking
    • 11.8.4 Strategic initiatives
  • 11.9 Teva Pharmaceutical Industries Ltd.
    • 11.9.1 Company overview
    • 11.9.2 Financial performance
    • 11.9.3 Product benchmarking
    • 11.9.4 Strategic initiatives
  • 11.10 Sun Pharmaceutical Industries Ltd.
    • 11.10.1 Company overview
    • 11.10.2 Financial performance
    • 11.10.3 Product benchmarking
    • 11.10.4 Strategic initiatives
  • 11.11 Dr. Reddy's Laboratories Ltd.
    • 11.11.1 Company overview
    • 11.11.2 Financial performance
    • 11.11.3 Product benchmarking
    • 11.11.4 Strategic initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global Active Pharmaceutical Ingredients Market, By Region, 2017 - 2028 (USD Billion)
  • TABLE 5 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 6 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 7 Global Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 8 Global Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 9 North America Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
  • TABLE 10 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 11 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 12 North America Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 13 North America Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 15 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 16 U.S. Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 17 U.S. Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 18 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 19 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 20 Canada Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 21 Canada Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 22 Europe Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
  • TABLE 23 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 24 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 25 Europe Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 26 Europe Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 27 U.K. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 28 U.K. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 29 U.K. Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 30 U.K. Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 31 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 32 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 33 Germany America Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 34 Germany America Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 35 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 36 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 37 France Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 38 France Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 39 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 40 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 41 Spain Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 42 Spain Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 43 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 44 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 45 Italy Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 46 Italy Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 47 Russia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 48 Russia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 49 Russia Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 50 Russia Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 51 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
  • TABLE 52 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 53 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 54 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 55 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 56 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 57 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 58 China Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 59 China Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 60 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 61 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 62 Japan Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 63 Japan Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 64 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 65 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 66 India Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 67 India Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 68 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 69 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 70 South Korea Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 71 South Korea Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 72 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 73 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 74 Australia Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 75 Australia Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 76 Latin America Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
  • TABLE 77 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 78 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 79 Latin America Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 80 Latin America Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 81 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 82 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 83 Brazil Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 84 Brazil Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 85 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 86 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 87 Mexico Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 88 Mexico Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 89 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 90 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 91 Argentina Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 92 Argentina Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 93 MEA Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
  • TABLE 94 MEA Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 95 MEA Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 96 MEA Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 97 MEA Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 98 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 99 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 100 South Africa Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 101 South Africa Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 102 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 103 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 104 UAE Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 105 UAE Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 106 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 107 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 108 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 109 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)

List of Figures

  • FIG. 1 API market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 API market, segment outlook
  • FIG. 10 API market, competitive outlook
  • FIG. 11 API market outlook (2020)
  • FIG. 12 Penetration & growth prospect mapping
  • FIG. 13 User perspective analysis
  • FIG. 14 Market driver relevance analysis (Current & future impact)
  • FIG. 15 Global percentage of the population, by age group, 2050 and 2000
  • FIG. 16 Market restraint relevance analysis (Current & future impact)
  • FIG. 17 Porter's five forces analysis
  • FIG. 18 PESTLE analysis
  • FIG. 19 Ansoff Matrix
  • FIG. 20 Heat map analysis
  • FIG. 21 Company market position analysis
  • FIG. 22 Company market position analysis
  • FIG. 23 Market differentiators
  • FIG. 24 Strategy mapping
  • FIG. 25 API market: Type of synthesis movement analysis
  • FIG. 26 Segment dashboard
  • FIG. 27 API market type of synthesis outlook: Key takeaways
  • FIG. 28 Biotech API market, 2017 - 2028 (USD Billion)
  • FIG. 29 Monoclonal antibodies market, 2017 - 2028 (USD Billion)
  • FIG. 30 Recombinant proteins market, 2017 - 2028 (USD Billion)
  • FIG. 31 Vaccines market, 2017 - 2028 (USD Billion)
  • FIG. 32 Synthetic API market, 2017 - 2028 (USD Billion)
  • FIG. 33 API market: Type of manufacturers movement analysis
  • FIG. 34 Segment dashboard
  • FIG. 35 API market type of manufacturers outlook: Key takeaways
  • FIG. 36 Captive API market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 37 Merchant API market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 38 API market: Type movement analysis
  • FIG. 39 Segment dashboard
  • FIG. 40 API market type outlook: Key takeaways
  • FIG. 41 Generic APIs market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 42 Innovative APIs market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 43 API market: Application movement analysis
  • FIG. 44 Segment dashboard
  • FIG. 45 API market application outlook: Key takeaways
  • FIG. 46 Cardiovascular diseases market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 47 Oncology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 48 CNS & neurology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 49 Orthopedics market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 50 Endocrinology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 51 Pulmonology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 52 Gastroenterology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 53 Nephrology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 54 Ophthalmology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 55 Others market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 56 Regional outlook, 2020 & 2028
  • FIG. 57 Regional market dashboard
  • FIG. 58 Regional market place: Key takeaways
  • FIG. 59 North America, SWOT Analysis
  • FIG. 60 Europe, SWOT Analysis
  • FIG. 61 Asia Pacific, SWOT Analysis
  • FIG. 62 Latin America, SWOT Analysis
  • FIG. 63 MEA, SWOT Analysis
  • FIG. 64 North America
  • FIG. 65 North America market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 66 U.S.
  • FIG. 67 U.S. market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 68 Canada
  • FIG. 69 Canada market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 70 Europe
  • FIG. 71 Europe market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 72 U.K.
  • FIG. 73 U.K. market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 74 Germany
  • FIG. 75 Germany market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 76 Spain
  • FIG. 77 Spain market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 78 France
  • FIG. 79 France market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 80 Italy
  • FIG. 81 Italy market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 82 Russia
  • FIG. 83 Russia market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 84 Asia Pacific
  • FIG. 85 Asia Pacific market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 86 Japan
  • FIG. 87 Japan market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 88 China
  • FIG. 89 China market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 90 India
  • FIG. 91 India market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 92 South Korea
  • FIG. 93 South Korea market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 94 Australia
  • FIG. 95 Australia market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 96 Latin America
  • FIG. 97 Latin America market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 98 Brazil
  • FIG. 99 Brazil market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 100 Mexico
  • FIG. 101 Mexico market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 102 Argentina
  • FIG. 103 Argentina market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 104 MEA
  • FIG. 105 MEA market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 106 South Africa
  • FIG. 107 South Africa market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 108 Saudi Arabia
  • FIG. 109 Saudi Arabia market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 110 UAE
  • FIG. 111 UAE market estimates and forecast, 2017 - 2028 (USD Billion)